Viewing nowHyel 20 mg Tablet (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

MFDS item code 201000970 · Approved 2010.01.28 · Insurance code 653804400
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunctive treatment when dietary and exercise control is difficult for patients with primary hypercholesterolemia and mixed dyslipidemia. It particularly helps lower LDL cholesterol levels in patients with familial hypercholesterolemia, aiding vascular health and slowing the progression of atherosclerosis. It is also used in pediatric patients aged 10 to 17 who meet the criteria for hyperlipidemia in conjunction with dietary management. Additionally, it can aid in the treatment of dysbetalipoproteinemia. The medication is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization procedures in adult patients at high risk of cardiovascular disease. Overall, it is used to improve hypercholesterolemia and the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The dose may be increased to a maximum of 20 milligrams per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be used by individuals with certain allergic reactions. It should not be administered to patients with active liver disease or severely impaired liver function. Patients with muscular diseases or past problems with muscles should also avoid using this medication. Caution is advised when taken with certain immunosuppressants. Patients with severely impaired kidney function or women who are pregnant or nursing should not use this medication. Patients at high risk of muscle damage should avoid high doses, and if they have risk factors, consultation with a doctor is required. This medication contains lactose and is not suitable for patients with lactose intolerance or other genetic metabolic issues. Individuals who consume large amounts of alcohol or have a history of liver disease should undergo regular liver function tests. If symptoms of muscle pain, weakness, or spasms occur, patients should inform their doctor immediately, and drug discontinuation may be necessary. This medication may increase blood sugar levels in some patients, so those at risk of diabetes should be monitored carefully. Liver function anomalies or rare skin adverse reactions may occur during treatment with this medication, so contact healthcare professionals immediately if symptoms arise. Drug interactions can occur, so if on other medications, patients must inform their doctor or pharmacist. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme tests may be needed. Dizziness may occur while driving or operating machinery, so caution is necessary. This medication may show higher blood concentration in Asians, so dose adjustment is important. Women of childbearing potential should use appropriate contraception and avoid use during pregnancy.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture. It is best kept at room temperature, between 1 and 30 degrees Celsius. This method of storage helps maintain the efficacy of the medication for a longer duration.
Pink round film-coated tablet
28 tablets (14 tablets/PTP*2), 30 tablets/bottle, 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.